Nair, Surag http://orcid.org/0000-0002-6216-2457
Barrett, Arjun http://orcid.org/0000-0002-8558-5188
Li, Daofeng http://orcid.org/0000-0001-7492-3703
Raney, Brian J.
Lee, Brian T.
Kerpedjiev, Peter
Ramalingam, Vivekanandan http://orcid.org/0000-0002-3631-8913
Pampari, Anusri http://orcid.org/0000-0002-6579-4070
Lekschas, Fritz
Wang, Ting http://orcid.org/0000-0002-6800-242X
Haeussler, Maximilian
Kundaje, Anshul http://orcid.org/0000-0003-3084-2287
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01HG009431, U01HG012069, 5U41HG002371, 5U41HG002371, R01HG007175, U01CA200060, U01HG009391, U41HG010972, U24HG012070, 5U41HG002371)
Article History
First Online: 14 October 2022
Competing interests
: A.K. is scientific co-founder of Ravel Biotechnology, is on the scientific advisory board of PatchBio, SerImmune, AINovo, TensorBio and OpenTargets, is a consultant with Illumina and owns shares in DeepGenomics, Immuni and Freenome. All other authors have no competing interests to declare.